Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.995
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Glycerol
|
HET
|
10f:10m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HET
|
10f:10m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HET
|
10f:10m
|
|
|
NotProcessed |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Lipase
|
HET
|
1f:2m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Simplified IPGTT / Blood glucose concentration
|
HET
|
50f:50m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Free fatty acids
|
HET
|
10f:10m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Triglycerides
|
HET
|
10f:10m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Total cholesterol
|
HET
|
10f:10m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Glucose
|
HET
|
10f:10m
|
|
|
NotProcessed |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Creatinine
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.397
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Fructosamine
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.685
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Glucose
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0995
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.287
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Urea
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.308
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Sodium
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.381
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Potassium
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.840
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alpha-amylase
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0174
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Iron
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.668
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total cholesterol
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0181
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total protein
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.609
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
6f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.131
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Albumin
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.180
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.169
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / UIBC (unsaturated iron binding capacity)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0984
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.464
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total bilirubin
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.590
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.855
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
DEXA / Fat/Body weight
|
HET
|
10f:10m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
DEXA / Fat mass
|
HET
|
10f:10m
|
|
|
NotProcessed |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
588f:672m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Calorimetry / Carbon dioxide production
|
HET
|
f:745m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.550
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Triglyceride
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.578
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Calorimetry / Oxygen consumption
|
HET
|
f:745m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Calorimetry / Heat production (metabolic rate)
|
HET
|
f:745m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Calcium
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.154
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Glucose
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.249
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Sodium
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.538
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.228
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
588f:672m
|
|
|
NotProcessed |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
6f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.357
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Potassium
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.405
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Phosphorus
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.736
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Chloride
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.163
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total protein
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.220
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.100
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Albumin
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00490
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Calcium
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.166
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Chloride
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.159
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Insulin Blood Level / Insulin
|
HET
|
6f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.979
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Calorimetry / Cumulative food intake
|
HET
|
f:745m
|
|
|
NotProcessed |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
35f:40m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.981
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Iron
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.214
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
3.01×10-06
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.231
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.388
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
8.85×10-06
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
5.79×10-05
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
588f:672m
|
|
|
NotProcessed |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HET
|
9f:11m
|
|
|
NotProcessed |
Epc2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.813
|
Successful |
Epc2tm1e(EUCOMM)Wtsi
|
WTSI
|
Simplified IPGTT / Glucose response AUC
|
HET
|
10f:10m
|
|
|
NotProcessed |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Triglycerides
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.124
|
Successful |
Epc2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0819
|
Successful |